SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-040861
Filing Date
2021-08-04
Accepted
2021-08-04 16:31:17
Documents
87
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sana-10q_20210630.htm   iXBRL 10-Q 3338796
2 EX-10.1 sana-ex101_185.htm EX-10.1 431647
3 EX-31.1 sana-ex311_9.htm EX-31.1 21142
4 EX-31.2 sana-ex312_7.htm EX-31.2 19625
5 EX-32.1 sana-ex321_8.htm EX-32.1 9774
6 EX-32.2 sana-ex322_10.htm EX-32.2 9488
7 GRAPHIC gb2b3lmghjof000001.jpg GRAPHIC 245379
  Complete submission text file 0001564590-21-040861.txt   12734722

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA sana-20210630.xsd EX-101.SCH 65712
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sana-20210630_cal.xml EX-101.CAL 53087
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sana-20210630_def.xml EX-101.DEF 229233
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sana-20210630_lab.xml EX-101.LAB 503328
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sana-20210630_pre.xml EX-101.PRE 414480
13 EXTRACTED XBRL INSTANCE DOCUMENT sana-10q_20210630_htm.xml XML 2430278
Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39941 | Film No.: 211144465
SIC: 2836 Biological Products, (No Diagnostic Substances)